GLP-1 receptor agonists are a growing class of therapies used in type 2 diabetes and, for some agents, chronic weight management
75 Further complementing PDCs design sophistication are innovative linkers, a cleverly designed example utilizes albumin metabolism to mediate apoptosis and trigger the expression of Caspase-3, which allows the PDC to remain persistently activated, enabling payload accumulation and subsequent bystander killing effects
Currently, except for LIR and SMG, the numbers of related clinical studies of other GLP-1R agonists are few, especially in obese or overweight people without diabetes
you know what you have to do
It delays gastric emptying , which can lead to side effects if consuming high-fat or greasy foods
These can be from hormone changes and stress to serious things like infections or problems with the cervix